NB-598

For research use only. Not for therapeutic Use.

  • CAT Number: I001189
  • CAS Number: 131060-14-5
  • Molecular Formula: C27H31NOS2
  • Molecular Weight: 449.67
  • Purity: ≥95%
Inquiry Now

NB-598(Cat No.:I001189) is a powerful competitive inhibitor of squalene epoxidase (SE), an enzyme involved in cholesterol biosynthesis. By inhibiting SE, NB-598 effectively suppresses triglyceride biosynthesis via the farnesol pathway. This pathway plays a crucial role in the production of triglycerides, a type of lipid involved in energy storage. By targeting SE, NB-598 disrupts the normal synthesis of triglycerides, providing a potential therapeutic approach for conditions related to abnormal lipid metabolism.


Catalog Number I001189
CAS Number 131060-14-5
Synonyms

(E)-N-(3-([3,3/’-bithiophen]-5-ylmethoxy)benzyl)-N-ethyl-6,6-dimethylhept-2-en-4-yn-1-amine

Molecular Formula C27H31NOS2
Purity ≥95%
Target Squalene epoxidase
Solubility DMSO 14 mg/ml
Storage Keep in dark place,Sealed in dry,Store in freezer, under -20°C
IUPAC Name (E)-N-ethyl-6,6-dimethyl-N-[[3-[(4-thiophen-3-ylthiophen-2-yl)methoxy]phenyl]methyl]hept-2-en-4-yn-1-amine
InChI InChI=1S/C27H31NOS2/c1-5-28(14-8-6-7-13-27(2,3)4)18-22-10-9-11-25(16-22)29-19-26-17-24(21-31-26)23-12-15-30-20-23/h6,8-12,15-17,20-21H,5,14,18-19H2,1-4H3/b8-6+
InChIKey KIRGLCXNEVICOG-SOFGYWHQSA-N
SMILES CCN(CC=CC#CC(C)(C)C)CC1=CC(=CC=C1)OCC2=CC(=CS2)C3=CSC=C3
Reference

<p style=/line-height:25px/>
<br>[1]. Xia F, Xie L, Mihic A, et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology. 2008 Oct;149(10):5136-45.

<br>[2]. Horie M, Iwasawa Y, Satoh T et al. Effects of NB-598, a potent squalene epoxidase inhibitor, on the apical membrane uptake of cholesterol and basolateral membrane secretion of lipids in Caco-2 cells. Biochem Pharmacol. 1993 Jul 20;46(2):297-305.

<br>[3]. Horie M, Hayashi M, Satoh T et al. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells. Biochim Biophys Acta. 1993 May 20;1168(1):45-51.

<br>[4]. Hidaka Y, Hotta H, Nagata Y, et al. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells. J Biol Chem. 1991 Jul 15;266(20):13171-7.

<br>[5]. Horie M, Tsuchiya Y, Hayashi M, et al. NB-598: a potent competitive inhibitor of squalene epoxidase. J Biol Chem. 1990 Oct 25;265(30):18075-8.

</p>

Request a Quote